Edition:
United Kingdom

Dr. Lal PathLabs Ltd (DLPA.NS)

DLPA.NS on National Stock Exchange of India

1,083.30INR
14 Jun 2019
Change (% chg)

Rs-7.10 (-0.65%)
Prev Close
Rs1,090.40
Open
Rs1,089.00
Day's High
Rs1,108.95
Day's Low
Rs1,065.20
Volume
386,963
Avg. Vol
76,901
52-wk High
Rs1,130.15
52-wk Low
Rs813.45

Latest Key Developments (Source: Significant Developments)

India's Dr. Lal Pathlabs Sept-Qtr Consol Profit Rises
Tuesday, 6 Nov 2018 

Nov 6 (Reuters) - Dr. Lal PathLabs Ltd ::SEPT QUARTER CONSOL NET PROFIT 570 MILLION RUPEES VERSUS PROFIT 506 MILLION RUPEES YEAR AGO.SEPT QUARTER CONSOL REVENUE FROM OPERATIONS 3.18 BILLION RUPEES VERSUS 2.78 BILLION RUPEES YEAR AGO.DECLARED INTERIM DIVIDEND OF 2.50 RUPEES PER SHARE.  Full Article

Dr. Lal Pathlabs Says Approved Appointment Of Ved Prakash Goel As CFO
Friday, 10 Aug 2018 

Aug 10 (Reuters) - Dr. Lal PathLabs Ltd ::SAYS APPROVED APPOINTMENT OF VED PRAKASH GOEL AS CHIEF FINANCIAL OFFICER.VED PRAKASH GOEL WILL TAKE OVER THE CFO AND KMP DUTIES & RESPONSIBILITIES WITH EFFECT FROM DILIP BIDANI.  Full Article

Dr.Lal Pathlabs Says NCLT Ordered Meetings of Shareholder, Unsecured Creditors For Amalgamation Scheme With Delta Ria And Pathology​​
Friday, 29 Dec 2017 

Dec 29 (Reuters) - Dr. Lal Pathlabs Ltd ::NCLT ORDERED MEETINGS OF SHAREHOLDERS, UNSECURED CREDITORS TO APPROVE SCHEME OF AMALGAMATION BETWEEN CO & DELTA RIA AND PATHOLOGY​.  Full Article

Dr. Lal Pathlabs Says Unit Approves Acquisition Of Satya Pathology And Diagnostic Centre
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - Dr. Lal Pathlabs Ltd ::SAYS UNIT APPROVES ACQUISITION OF SATYA PATHOLOGY AND DIAGNOSTIC CENTRE.SAYS COST OF ACQUISITION NOT EXCEEDING 20 MILLION RUPEES.  Full Article

India's Dr. Lal Pathlabs Sept-qtr profit falls
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Dr. Lal Pathlabs Ltd ::Sept quarter profit 502 million rupees versus 528 million rupees year ago.Sept quarter revenue from operations 2.69 billion rupees versus 2.53 billion rupees year ago.Declared interim dividend of 1.50 rupees per share.  Full Article

Dr. Lal Pathlabs approves acquisition of 70 pct stake in Dr. Lal Path Labs Bangladesh
Monday, 7 Aug 2017 

Aug 7 (Reuters) - Dr. Lal Pathlabs Ltd ::Says approved acquisition of a company in Bangladesh.Says co to acquire 70 percent stake in Dr Lal Path Labs Bangladesh Pvt Ltd for not more than 181.49 taka per share.  Full Article

India's Dr. Lal Pathlabs June-qtr consol profit rises
Monday, 7 Aug 2017 

Aug 7 (Reuters) - Dr. Lal Pathlabs Ltd ::June quarter consol profit 444 million rupees versus profit 400 million rupees year ago.June quarter consol total income 2.57 billion rupees versus 2.29 billion rupees year ago.  Full Article